Lidocaine to Prevent Ventricular Fibrillation in Early Acute Myocardial Infarction

John S. Edelsberg, Warren H. Gullen, H. M. Dunn, A. A.J. Adgey, Paul Kuritzky, James A. Reiffel, Curt R. Freed, Daniel David, Elieser Kaplinsky, Rudolph W. Koster, Arend J. Dunning, Bernard Lown

Research output: Contribution to journalLetterpeer-review


To the Editor: In the October 31 issue of the Journal, Koster and Dunning1 describe their study of the prophylactic use of lidocaine in presumed cases of myocardial infarction. Unfortunately, certain caveats that should be considered in interpreting the results were not adequately addressed in the article. First, although the authors refer to the study as double blind, the control subjects did not receive an injection. Thus, one wonders how much of the apparent effectiveness of the lidocaine was attributable to a direct pharmacologic action and how much to a placebo effect (possibly mediated by a decrease in catecholamines….

Original languageEnglish
Pages (from-to)1116-1118
Number of pages3
JournalNew England Journal of Medicine
Issue number17
StatePublished - 24 Apr 1986


Dive into the research topics of 'Lidocaine to Prevent Ventricular Fibrillation in Early Acute Myocardial Infarction'. Together they form a unique fingerprint.

Cite this